Harmony Biosciences 8-K Report: Key Insights & Filing Details

Here are the key insights extracted from the provided section of the financial report:
- Entity Information:
- Company Name: Harmony Biosciences Holdings, Inc.
- CIK: 0001802665
- State of Incorporation: Delaware (DE)
- SEC File Number: 001-39450
- EIN: 82-2279923
- Address: 630 W. Germantown Pike, Suite 215, Plymouth Meeting, PA 19462
- Phone Number: 484-539-9800
- Filing Details:
- Filing Type: 8-K
- Filing Date: February 25, 2025
- Stock Information:
- Common Stock Par Value: $0.00001 per share
- Stock Symbol: HRMY
- Exchange: NASDAQ
- Reporting Period:
- Start Date: February 25, 2025
- End Date: February 25, 2025
- XML and Schema Reference:
- The report is structured in XBRL format, and it references an XSD schema file named
hrmy-20250225.xsd
.
Summary:
This section provides essential details about Harmony Biosciences Holdings, Inc., including its identification information, stock details, and the nature of the financial filing (8-K). The report is a short-period filing dated February 25, 2025, indicating a specific event or change in the company’s status that necessitated reporting to the SEC.